京津沪生物医药产业比较研究及对天津的启示

A Comparative Study on Bio-Pharmaceutical Industry in Beijing-Tianjin-Shanghai Region and Its Enlightenment to Tianjin

通过对京津沪3个直辖市的比较分析发现,天津生物医药产业的布局和结构呈现出单个企业实力较强、产业集中度高、产值复合增长率高、规模效率明显等优势。并已形成化学药、中药、生物药、医疗器械和健康产业"五轮驱动"的发展格局。但也存在医药企业数量少、过亿产品数量少、结构不合理等问题。因此,天津未来应借助产业和园区集中度高的优势,实施重大项目带动战略,调整优化医药产业的内部结构和重点领域,培育一批成长性好、市场潜力大的优势药企,把吸引跨国药企研发和制造中心作为招商引资的重点,依托京津冀科技和人才资源做大产业支撑平台和服务平台,使生物医药产业成为经济发展的新增长点。

Through a comparative study on bio-pharmaceutical industry in Beijing,Tianjin and Shanghai,we found that the layout and structure of the bio-pharmaceutical industry in Tianjin has many advantages such as stronger competitiveness for individual enterprises,higher bio-pharmaceutical industry concentrating ratio,higher compound growth rate and greater scale efficiency,and it has formed ＂five-driven＂development pattern of chemical drugs,traditional Chinese medicine,bio-medicine,medical equipment and health industry. But there also exist some defectives such as few pharmaceutical enterprises,a small number of high added value products and irrational industrial structure etc. Therefore,in future of Tianjin we should implement a series of major projects by taking advantage of its industrial concentration features,so as to optimize the internal structure and key fields of bio-pharmaceutical industry. We would like to cultivate a group of pharmaceutical companies with enormous potentials and wide marketing prospect to encourage foreign enterprises to invest and build factories in Tianjin. Relying on high-quality human resources in Beijing-Tianjin-Hebei region,we will expand industrial support and service platform,so that the bio-pharmaceutical industry could become a new growth point of economic development.